This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Lysnyansky, I.
Right arrow Articles by Levisohn, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lysnyansky, I.
Right arrow Articles by Levisohn, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2009, p. 4911-4914, Vol. 53, No. 11
0066-4804/09/$08.00+0     doi:10.1128/AAC.00703-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Rapid Detection of a Point Mutation in the parC Gene Associated with Decreased Susceptibility to Fluoroquinolones in Mycoplasma bovis{triangledown}

I. Lysnyansky,* I. Mikula, I. Gerchman, and S. Levisohn

Mycoplasma Unit, Division of Avian and Aquatic Diseases, Kimron Veterinary Institute, Bet Dagan, Israel

Received 26 May 2009/ Returned for modification 10 July 2009/ Accepted 22 August 2009

Comparison of the quinolone resistance-determining regions (QRDRs) in 42 Mycoplasma bovis clinical isolates revealed amino acid substitutions at both GyrA (position 83) and ParC (position 84) in 10/11 enrofloxacin-resistant strains. The mutation present in the parC QRDR was discriminative for enrofloxacin resistance by parC PCR-restriction fragment length polymorphism. Comparison of molecular profiles by insertion sequence typing suggests that the currently prevalent enrofloxacin-resistant M. bovis strain evolved by selection under field conditions from one of the susceptible strains.


* Corresponding author. Mailing address: Division of Avian and Aquatic Diseases, Kimron Veterinary Institute, POB 12, Bet Dagan 50250, Israel. Phone: 972 3 9681617. Fax: 972 3 9681739. E-mail: innal{at}moag.gov.il

{triangledown} Published ahead of print on 31 August 2009.


Antimicrobial Agents and Chemotherapy, November 2009, p. 4911-4914, Vol. 53, No. 11
0066-4804/09/$08.00+0     doi:10.1128/AAC.00703-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.